Labdia Labordiagnostik GmbH (Lab Dia)

Labdia Labordiagnostik GmbH (Labdia)

Organisational Structure

Medical Director: Univ.-Prof. DDr. Thomas Lion (MD, PhD), MSc
Vice-Medical Director: Univ.-Prof. Dr. Oskar A. Haas (MD)
Management: Univ.-Prof. Dr. Prof. Wolfgang Holter (MD)/Mag. Jörg Bürger (MSc), MBA
Secretary: Brigitte Glatz

Divison of Molecular Genetic Analysis and Molecular Microbiology
Prof. Thomas Lion, MD, PhD, MSc / Ing. Helga Daxberger / DI Dragana Jugovic / Michaela Nesslböck / Sandra Preuner, MSc / Susanna Koskela, MSc / Lisa Größlinger, BSc / Gisela Hofmann, BSc

Division of Cytogenetics and Molecular Cytogenetics
DI Clemens Brunner / Ulrike Engel / Brigitte Grimm / Sabrina Haslinger, MSc / Andrea Inthal, PhD / Margit König / DI Michael Kainz / Bettina Nocker / Maya Plank, BSc / Eva Winkler / Sven Wohlmacher, MSc

Division of Pharmacological Analysis
Assoc. Prof. Ulrike Kastner, MD, PhD / Ulrike Engel / Eva Winkler

The following CCRI working groups and staff contribute to the activities of diagnostics provided by Labdia:

Clinical Cell Biology & FACS Core Unit Group
Assoc. Prof. René Geyeregger, PhD / Assoc. Prof. Gerhard Fritsch, PhD / Christine Hoffmann-Freimüller, MSc / Angela Halfmann, MSc / Ing. Dieter Printz / Julia Stemberger / Dijana Trbojevic / Elke Zipperer / Daniela Scharner

Immunological Diagnostics Group
Assoc. Prof. Michael Dworzak, MD
Angela Schumich / Susanne Suhendra

Biology of Leukaemias Group
Prof. Renate E. Panzer-Grümayer, MD
Susanne Fischer / Astrid Mecklenbräuker

Tumour Biology Group
Assoc. Prof. Peter Ambros, PhD
Ingeborg M. Ambros, MD / Bettina Brunner / Andrea Ziegler

About the company

The SME Labdia Labordiagnostik GmbH was established in the year 2006 (with Prof. Thomas Lion, MD, PhD, MSc, as Medical Director) as a nonprofit subsidiary of the St. Anna Children’s Cancer Research Association, with the aim of promoting development and offering innovative diagnostic approaches. The main areas of our activity include haematology/oncology and infectiology.

In close cooperation with the St. Anna Children’s Cancer Research Institute (CCRI) and other national and international research centers, we are continuously establishing and validating new assays and introducing them into clinical diagnostics. All diagnostic tests provided are based on our own developments, some of which have been patented. We actively participate in national and international boards focusing on the standardization of different diagnostic methodologies, and have coordinated European activities in the field of diagnostic development in projects supported by the EU. Owing to the established network with other leading diagnostic centers in Europe, our regular participation in national and international control rounds, and our tight links with research and development, Labdia has access to the latest technical know-how and offers high competence in specialized diagnostic services.

In addition to our activities as a diagnostic reference center for national and international therapeutic trials, Labdia also offers its services to individual patients treated at various centers in Austria and other countries. The most important diagnostic methodologies currently offered by Labdia include molecular genetic testing, cytogenetic analyses, fluorescence in situ hybridization (FISH) assays, pharmacokinetic analyses, flow cytometry and cell sorting by FACS, as well as investigation of DNA mutations by various techniques. Labdia is an internationally certified competence center for comprehensive diagnostics of pediatric solid tumors and acute leukemias as well as chronic myeloid leukemia (CML), which is an important focus within our spectrum of diagnostic activities.  The current range of diagnostic tests also covers inherited genetic disorders, and a comprehensive compilation of analyses offered by individual divisions of Labdia Labordiagnostik is displayed on our website